Premium Nahrungsergänzungsmittel | artgerecht

Glandular Atrophy: Causes, Symptoms & Treatment

Glandular atrophy refers to the pathological shrinkage or loss of glandular tissue, leading to reduced or absent secretory function of the affected gland.

Regular tips about health Regular tips about health

Things worth knowing about "Glandular Atrophy"

Glandular atrophy refers to the pathological shrinkage or loss of glandular tissue, leading to reduced or absent secretory function of the affected gland.

What is Glandular Atrophy?

Glandular atrophy is a medical condition characterized by the reduction in size, cell number, or functional capacity of glandular tissue. Glands are specialized structures responsible for producing and releasing substances such as hormones, enzymes, and other secretions essential for normal body function. When glandular tissue undergoes atrophy, the affected gland can no longer perform its physiological role adequately.

Glandular atrophy can affect virtually any gland in the human body, including the thyroid gland, pancreas, adrenal glands, salivary glands, and gastric glands. The clinical significance, symptoms, and management depend greatly on which gland is involved and the extent of tissue loss.

Causes

Glandular atrophy can arise from a variety of causes:

Autoimmune diseases: The immune system mistakenly attacks and destroys glandular tissue. Well-known examples include Hashimoto thyroiditis (thyroid) and atrophic gastritis (gastric glands).
Chronic inflammation: Persistent inflammatory processes can progressively damage and destroy glandular cells.
Hormonal deficiencies: Lack of stimulating hormones (e.g., TSH deficiency in the thyroid) can lead to functional atrophy due to insufficient stimulation.
Reduced blood supply (ischemia): Insufficient blood flow deprives glandular tissue of oxygen and nutrients, leading to cell death.
Aging: Physiological aging is associated with a natural decline in glandular cell number and secretory function in many glands.
Radiation therapy or medications: Certain medical treatments can damage glandular tissue and contribute to atrophy.
Infections: Viral or bacterial infections may cause permanent damage to glandular structures.

Symptoms

The symptoms of glandular atrophy depend on which gland is affected and the degree of functional impairment:

Thyroid atrophy: Fatigue, weight gain, cold intolerance, dry skin, constipation (signs of hypothyroidism).
Gastric gland atrophy (atrophic gastritis): Digestive discomfort, vitamin B12 deficiency, anemia, upper abdominal pain.
Adrenal cortex atrophy: Severe fatigue, low blood pressure, electrolyte imbalances (signs of adrenal insufficiency).
Salivary gland atrophy: Dry mouth (xerostomia), difficulty swallowing, increased risk of dental caries.
Pancreatic atrophy: Digestive problems, fatty stools, and diabetes mellitus if the endocrine function is impaired.

Diagnosis

Diagnosing glandular atrophy typically involves a combination of the following approaches:

Blood tests: Measurement of hormones, enzymes, and autoantibodies to evaluate glandular function and detect autoimmune processes.
Imaging: Ultrasound, MRI, or CT scans can visualize the size and structural changes of the affected gland.
Tissue biopsy: Microscopic examination of glandular tissue provides detailed information about cellular changes and degree of atrophy.
Functional tests: Specific tests assess secretory capacity (e.g., glucose tolerance test for pancreatic involvement).

Treatment

Treatment is tailored to the underlying cause and the specific gland involved. Since true regeneration of atrophied glandular tissue is generally not possible, therapy primarily focuses on replacing the lost function:

Hormone replacement therapy: In thyroid atrophy, the missing thyroid hormone (levothyroxine) is supplemented. Adrenal cortex atrophy requires corticosteroid replacement.
Enzyme replacement therapy: In exocrine pancreatic insufficiency, oral digestive enzymes (pancreatin) are prescribed to support digestion.
Vitamin and nutrient supplementation: Atrophic gastritis often requires vitamin B12 injections or high-dose oral supplementation.
Treatment of the underlying condition: Autoimmune causes may be managed with immunomodulatory or other targeted therapies.
Symptomatic measures: Saliva substitutes for salivary gland atrophy, and dietary counseling for digestive impairment.

Prognosis and Follow-Up

Glandular atrophy often follows a chronic course and may progress without treatment. With appropriate replacement therapy, most patients can maintain a good quality of life. Regular follow-up examinations are essential to adjust treatment and detect complications early. In conditions such as atrophic gastritis, there is an increased risk of gastric cancer, making close monitoring particularly important.

References

Kumar, V., Abbas, A. K., Aster, J. C. - Robbins and Cotran Pathologic Basis of Disease. 10th ed. Elsevier, Philadelphia, 2021.
Greenspan, F. S., Gardner, D. G. - Basic and Clinical Endocrinology. 9th ed. McGraw-Hill, New York, 2011.
World Health Organization (WHO) - International Classification of Diseases (ICD-11), 2023. Available at: https://icd.who.int

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.